In another study performed on Swiss patients with NMZL, Pillonel et al. reported recurrent BRAF mutations, suggesting that BRAF mutations are diagnostically and therapeutically useful [7]. The gene discussed is BRAF; the disease is nodal marginal zone B-cell lymphoma.